Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.91
0.061.56%
Molecular Partners AG Analyst Ratings
MOLNNASDAQ
Molecular Partners Analyst Ratings and Price Targets | NASDAQ:MOLN | Benzinga
Molecular Partners AG has a consensus price target of $9.58 based on the ratings of 3 analysts. The high is $13 issued by HC Wainwright & Co. on April 22, 2026. The low is $3.75 issued by JP Morgan on December 8, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 22, 2026, March 16, 2026, and January 27, 2026, respectively. With an average price target of $13 between HC Wainwright & Co., there's an implied 232.48% upside for Molecular Partners AG from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JP Morgan
LifeSci Capital
1calculated from analyst ratings
Analyst Ratings for Molecular Partners
Loading calendar...
FAQ
What is the target price for Molecular Partners (MOLN) stock?
The latest price target for Molecular Partners (NASDAQ:MOLN) was reported by HC Wainwright & Co. on April 22, 2026. The analyst firm set a price target for $13.00 expecting MOLN to rise to within 12 months (a possible 232.48% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Molecular Partners (MOLN)?
The latest analyst rating for Molecular Partners (NASDAQ:MOLN) was provided by HC Wainwright & Co., and Molecular Partners reiterated their buy rating.
When was the last upgrade for Molecular Partners (MOLN)?
There is no last upgrade for Molecular Partners
When was the last downgrade for Molecular Partners (MOLN)?
There is no last downgrade for Molecular Partners.
When is the next analyst rating going to be posted or updated for Molecular Partners (MOLN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molecular Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molecular Partners was filed on April 22, 2026 so you should expect the next rating to be made available sometime around April 22, 2027.
Is the Analyst Rating Molecular Partners (MOLN) correct?
While ratings are subjective and will change, the latest Molecular Partners (MOLN) rating was a reiterated with a price target of $13.00 to $13.00. The current price Molecular Partners (MOLN) is trading at is $3.91, which is out of the analyst’s predicted range.
